—CPRT
— • —
$32.76
P/E
20.55
PEG
0.03
FCF Yield
—
Rev Growth YoY
+238.0% YoY
Gross Margin
4534.0%
Health Score
7/10
D/E Ratio
—
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this payload, making it impossible to describe the company's business, sector, or industry with confidence. What is available suggests a small or micro-cap entity based on the limited market data provided. Without a confirmed market capitalisation figure, precise cap-tier classification cannot be made, though the data profile is consistent with an early-stage or thinly covered company.
Financial Health
Score: 7/10
The balance sheet appears notably clean, with a debt-to-equity ratio of 0.0x — meaning the company carries no financial leverage risk. The current ratio of 8.42x signals strong short-term liquidity, suggesting the company can comfortably cover near-term obligations...
Risk Assessment
- DATA QUALITY: Gross margin of 4,534% and net margin of 3,376% are arithmetically implausible for most business models and strongly suggest data errors or non-standard accounting classifications.
- MISSING FUNDAMENTALS: TTM Revenue, TTM Net Income, and Free Cash Flow are all unavailable, making comprehensive financial analysis impossible.
- TECHNICALS: A confirmed death cross (50-day MA crossing below 200-day MA) is an established bearish signal, compounded by a bearish MACD reading.
- PRICE POSITIONING: The current price sits below both the 50-day and 200-day moving averages, indicating the stock is in a sustained downtrend relative to its own recent history.
- ANALYST COVERAGE: Only 60% of analysts rate this a buy — with 35% at hold — and no average price target is available to benchmark the current price of $32.76 against consensus expectations.
---...
**Score: 7/10** The balance sheet appears notably clean, with a debt-to-equity ratio of 0.0x — meaning the company carries no financial leverage risk. The current ratio of 8.42x signals strong short-term liquidity, suggesting the company can comfortably cover near-term obligations. However, free cash flow is unavailable, which prevents a full assessment of cash generation quality, capping this score despite the headline strength. ---
- **DATA QUALITY: Gross margin of 4,534% and net margin of 3,376% are arithmetically implausible for most business models and strongly suggest data errors or non-standard accounting classifications.** - **MISSING FUNDAMENTALS: TTM Revenue, TTM Net Income, and Free Cash Flow are all unavailable, making comprehensive financial analysis impossible.** - **TECHNICALS: A confirmed death cross (50-day MA crossing below 200-day MA) is an established bearish signal, compounded by a bearish MACD reading.** - **PRICE POSITIONING: The current price sits below both the 50-day and 200-day moving averages, indicating the stock is in a sustained downtrend relative to its own recent history.** - **ANALYST COVERAGE: Only 60% of analysts rate this a buy — with 35% at hold — and no average price target is available to benchmark the current price of $32.76 against consensus expectations.** ---
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives